Voicing politics: How language impacts political opinions
In a new book, “Voicing Politics,” Arts & Sciences’ Margit Tavits uncovers the many ways in which linguistic peculiarities of different languages can have meaningful consequences for political attitudes and beliefs around the world.
WashU, pharmacy scientists alter fentanyl, aim to make it less lethal, less addictive
A research team that includes School of Medicine and pharmacy scientists has altered the chemical properties of fentanyl. The research holds promise for developing safer opioid drugs that still relieve pain.
Findings from 3,000-year-old Uluburun shipwreck reveal complex trade network
Using advanced geochemical analyses, a team of scientists, including Michael Frachetti, professor of archaeology in Arts & Sciences, have uncovered new answers to decades-old questions about trade of tin throughout Eurasia during the Late Bronze Age.
Embodying cognition
Elinor Harrison, a postdoctoral fellow in physical therapy and in dance, will present a new duet choreographed for twin dance majors Ali and Juli Yaniz as part of “This is Temporary,” the 2022 WashU Dance Theatre concert.
Machine learning model builds on imaging methods to better detect ovarian lesions
Research from Quing Zhu’s lab at the McKelvey School of Engineering yields a novel method to use ultrasound to enhance machine learning’s ability to accurately diagnose — or rule out — ovarian cancer.
More frequent CT scans not associated with improved outcomes after lung cancer surgery
A new study by researchers at Washington University School of Medicine found that undergoing more frequent computed tomography (CT) scans was not associated with improved outcomes following lung cancer surgery.
Diagnostic marker found for deadly brain disease marked by dementia, movement problems
Researchers at Washington University School of Medicine have discovered a biomarker for a rare, deadly brain disease known as corticobasal degeneration (CBD). The biomarker could accelerate efforts to develop treatments for CBD.
Drug triggers immune cells to attack prostate cancer
A drug compound attacks hard-to-treat prostate cancer on several fronts, according to a School of Medicine study in mice and human cells. It triggers immune cells to attack, helps the immune cells penetrate the tumor and cuts off the tumor’s ability to burn testosterone as fuel.
Leaders provide update, next steps on ‘Here and Next’
Washington University in St. Louis’ strategic vision, “Here and Next,” is moving into its next phase: implementation planning.
Forest Park Living Lab
Combining experts in wildlife ecology, animal movement and veterinary medicine, the new Forest Park Living Lab examines wildlife health, behavior and interactions in the mosaic of ecosystems in Forest Park. The project received a Living Earth Collaborative seed grant in 2020.
View More Stories